#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemolytic uraemic syndrome Proteus syndrome Hyperadrenocorticism Castleman's disease Infantile spasms Pleural mesothelioma malignant Myelodysplastic syndrome with excess blasts Squamous cell carcinoma of the hypopharynx Osteomyelitis Small intestine neuroendocrine tumour Familial haemophagocytic lymphohistiocytosis Amyloidosis Thalassaemia alpha Plasma cell myeloma recurrent Subdural haematoma More trials…

    Learn about Rare Diseases

    Angiosarcoma – Diagnostics Pulmonary fibrosis – Trials in Disease Phenylketonuria – Diagnostics Acute respiratory distress syndrome – Trials in Disease Friedreich’s ataxia Haemolytic uraemic syndrome – Basic Information Fabry’s disease – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Cholangitis sclerosing – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Poloxamer 407 Meclofenamate Sodium Dimeticone 20-HYDROXYECDYSONE Mosliciguat Febuxostat Df1001 Emtricitabine Elacestrant Dihydrochloride Erythromycin Lactobionate Baxdrostat Mebufotenin Vibegron Revumenib Cenobamate Pralsetinib Voxelotor Glofitamab Doconexent Belimumab More therapies…

    Learn about Your Condition

    Asymptomatic HIV infection Laparoscopic surgery Sleep disorder Adenocarcinoma Encephalitis autoimmune Tumour of ampulla of Vater Glioblastoma Immune thrombocytopenia Oral neoplasm Plasma cell leukaemia Mitochondrial myopathy Sepsis Breast cancer in situ Oesophageal adenocarcinoma Antithrombin III deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    Poland

  • Study of the effectiveness and safety of colesevelam hydrochloride for patients with moderate-to-severe bile acid diarrhoea.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • COLESEVELAM HYDROCHLORIDE
    • Loperamide Hydrochloride
    Italy

  • A study of tirzepatide and levonorgestrel in women with endometrial cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial adenocarcinoma
    Investigated Drugs:
    • Levonorgestrel
    • Tirzepatide
    Ireland

  • A study of botulinum toxin type A versus placebo to treat bowel movement problems in patients recovering from surgery for rectal cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium

  • Study evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Levetiracetam
    France

  • A study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Vestibular disorder
    Investigated Drugs:
    • Levothyroxine Sodium
    • Placebo
    Germany
Previous Page
1 … 727 728 729 730 731 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!